Serina Therapeutics, Inc. Research and Development in Process
Serina Therapeutics, Inc. (SER) reported Research and Development in Process of $800.00 thousand for the 12-month period ending 2018-12-31, per its 10-K/A filed 2020-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2020-03-31
- Serina Therapeutics, Inc. research and development in process for the quarter ending 2018-12-31 was $0.00.
- Serina Therapeutics, Inc. research and development in process for the quarter ending 2018-09-30 was $0.00.
- Serina Therapeutics, Inc. research and development in process for the quarter ending 2018-06-30 was $0.00.
- Serina Therapeutics, Inc. research and development in process for the quarter ending 2018-03-31 was $800.00K.
- Serina Therapeutics, Inc. research and development in process for fiscal 2018 was $800.00K.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $0.00 derived: sum of 2 quarters · filed 2020-03-31 | $0.00 derived: sum of 3 quarters · filed 2020-03-31 | $800.00K 10-K/A · filed 2020-03-31 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $800.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $800.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $800.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |